Symetis AG

http://www.symetis.com

Symetis, founded in 2001, is a medical technology company specializing in the development, manufacturing and marketing of percutaneous heart valve replacement solutions for the treatment of severe cardiac valve conditions. Symetis’ products, ACURATE TA™ and ACURATE neo/TF, and their delivery systems are based on proprietary design and delivery technologies and are marketed and sold in key markets in Europe and in other geographies. Symetis’ innovative TAVI solutions are recognized by intervention cardiologists and surgeons for their clinical performance and ease of use. Growing at a strong and sustained CAGR of 55% since 2012, the company generated revenues of CHF 38.4 million in 2016. Symetis is a Swiss company with corporate headquarters in Ecublens, Switzerland and its products are produced in Switzerland and Brazil. *

	Start	2001-01-01 splitoff
	Group	Boston Scientific (Group)
	Predecessor	University of Zurich (UZH)
	Industry	tissue engineering / regenerative medicine
	Industry 2	medical device
	Person	Essinger, Jacques R. (Symetis 201703 CEO)

	Region	Ecublens VD
	Country	Switzerland
	Street	11 Chemin de la Venoge
	City	1024 Ecublens VD
	Tel	+41-21-651-0160
		Address record changed: 2018-07-24

Basic data	Employees	D: 101 to 500 (2017-03-30)
	Currency	CHF
	Annual sales	38,400,000 (revenues (2016) 2016-12-31)

		* Document for ï¿½About Sectionï¿½: Symetis AG. (3/30/17). "Press Release: Symetis and Boston Scientific Reach USD 435 Million Purchase Agreement". Ecublens.

		Record changed: 2019-12-15